Last reviewed · How we verify

NCT05236153

Electroanatomic Interactions Between Transcatheter Pulmonary Valve Prostheses and Anatomic Isthmuses in Repaired Tetralogy of Fallot

Status unknown NA Last updated 8 February 2023
What this trial tests

NA trial testing Electroanatomic substrate mapping in Tetralogy of Fallot in 60 participants. Status unknown.

Timeline
4 November 2022
Primary endpoint
3 November 2023
1 January 2024

Quick facts

Lead sponsorBoston Children's Hospital
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposediagnostic
Enrollment60
Start date4 November 2022
Primary completion3 November 2023
Estimated completion1 January 2024
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Boston Children's Hospital

Who can join

Eligibility, any sex, with Tetralogy of Fallot or Ventricular Tachycardia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Individuals with repaired Tetralogy of Fallot (rTOF) remain at risk for sudden cardiac death from ventricular tachycardia (VT). Transcatheter pulmonary valve replacement (TPVR) indications continue to broaden, yet its capability to reduce the risk of VT and sudden cardiac death remains unknown. Thus, in a cohort of participants with rTOF who are presenting for TPVR the investigators intend to: (1) quantify and localize right ventricular (RV) isthmuses with abnormal voltage and/or conduction velocity; (2) identify which RV isthmuses are at risk of being "jailed" by TPV prostheses; and (3) explore the feasibility of omnipolar technology to characterize wavefront directionality and differentiate slow conduction from conduction block.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Tetralogy of Fallot

Currently open trials in the same condition.

Other Boston Children's Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05236153.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing